Japanese Journal of Cancer Clinics 1985-09-01

[Cutaneous delayed hypersensitivity to costus root oil in lung cancer].

I Takanami, T Ishihara, N Yanai

Index: Gan No Rinsho. 31(11) , 1362-6, (1985)

Full Text: HTML

Abstract

Costus root oil is a new primary sensitizer for examining the delayed, cell-mediated immune system. Ninety-nine patients with lung cancer were tested for skin reactions to costus root oil. The incidence of positive reactions to costus root oil decreased with the progress of lung cancer. The percentage of lung cancer patients who survived was significantly greater for positive than for negative patients. This study shows that skin reactions to costus root oil are related the tumor growth and prognosis in lung cancer.


Related Compounds

Related Articles:

[Newly recognized primary sensitizers, methyl heptine carbonate and costus root oil to evaluate cutaneous delayed hypersensitivity on various chest diseases (author's transl)].

1981-07-01

[Nihon Kyobu. Shikkan Gakkai Zasshi 19(7) , 478-86, (1981)]

Molecular recognition patterns of sesquiterpene lactones in costus-sensitive patients.

1986-10-01

[Contact Dermatitis 15(4) , 223-30, (1986)]

Dioxopromethazine-induced photoallergic contact dermatitis followed by persistent light reaction.

1998-09-01

[Am. J. Contact Dermatitis 9(3) , 182-7, (1998)]

[Skin sensitization of costus root oil and peripheral lymphocyte count in gastric and colon cancers].

1984-01-01

[Gan To Kagaku Ryoho. 11(1) , 81-6, (1984)]

[Costus root oil test in cancer patients; correlation with tumor stage].

1983-09-01

[Gan No Rinsho. 29(11) , 1319-22, (1983)]

More Articles...